Takumi Kawaguchi

Dr. Takumi Kawaguchi

Kurume University School of Medicine
orcid

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2017 in Journal of Hepatology
Verified
Journal Article
Closed access
RHRyuki Hashida
Ryuki Hashida
Takumi KawaguchiTakumi Kawaguchi
Takumi Kawaguchi
MBMasafumi Bekki
Masafumi Bekki
MOMasayuki Omoto
Masayuki Omoto
HMHiroo Matsuse
Hiroo Matsuse
TTTakuji Torimura
Takuji Torimura

1 November 2004 in The American Journal of Pathology
Verified
Journal Article
Closed access
Takumi KawaguchiTakumi Kawaguchi
Takumi Kawaguchi
TYTakafumi Yoshida
Takafumi Yoshida
MHMasaru Harada
Masaru Harada
THTakao Hisamoto
Takao Hisamoto
YNYumiko Nagao
Yumiko Nagao
MSMichio Sata
Michio Sata

30 November 2020 in Liver International
Verified
Journal Article
Closed access
SYSakura Yamamura
Sakura Yamamura
MEMohammed Eslam
Mohammed Eslam
Takumi KawaguchiTakumi Kawaguchi
Takumi Kawaguchi
TTTsubasa Tsutsumi
Tsubasa Tsutsumi
DNDan Nakano
Dan Nakano
TTTakuji Torimura
Takuji Torimura

11 May 2011 in Hepatology
Verified
Journal Article
Open access
PDF file
Takumi KawaguchiTakumi Kawaguchi
Takumi Kawaguchi
NINamiki Izumi
Namiki Izumi
MCMichael R. Charlton
Michael R. Charlton
MSMichio Sata
Michio Sata
Branched-chain amino acids (BCAAs) are a group of essential amino acids comprising valine, leucine, and isoleucine. A low ratio of plasma BCAAs to aromatic amino acids is a physiological hallmark of liver cirrhosis, and BCAA supplementation was originally devised with the intention of normalizing amino acid profiles and nutritional status. However, recent studies on BCAAs have revealed that, in addition to their role as protein constituents, they may have a role as pharmacological nutrients for patients with chronic liver disease. Large-scale, multicenter, randomized, double-blinded, controlled trials on BCAA supplementation have been performed in Italy and Japan, and results demonstrate that BCAA supplementation improves not only nutritional status, but also prognosis and quality of life in patients with liver cirrhosis. Moreover, accumulating experimental evidence suggests that the favorable effects of BCAA supplementation on prognosis may be supported by unforeseen pharmacological actions of BCAAs. This review summarizes the possible effects of BCAAs on albumin synthesis and insulin resistance from clinical and basic viewpoints. We also review the newly discovered clinical impact of BCAAs on hepatocellular carcinoma and the prognosis and quality of life of patients with liver cirrhosis. (HEPATOLOGY 2011;)

1 January 2013 in World Journal of Gastroenterology
Verified
Journal Article
Open access
MIMinoru Itou
Minoru Itou
Takumi KawaguchiTakumi Kawaguchi
Takumi Kawaguchi
ETEitaro Taniguchi
Eitaro Taniguchi
MSMichio Sata
Michio Sata
Dipeptidyl peptidase-4: A key player in chronic liver disease

15 June 2021 in Hepatology Research
Verified
Journal Article
Closed access
PDF file
TTTsubasa Tsutsumi
Tsubasa Tsutsumi
MEMohammed Eslam
Mohammed Eslam
Takumi KawaguchiTakumi Kawaguchi
Takumi Kawaguchi
SYSakura Yamamura
Sakura Yamamura
AKAtsushi Kawaguchi
Atsushi Kawaguchi
TTTakuji Torimura
Takuji Torimura